DBT announces COVID-19 research consortium

25 March 2020 | News

Urgent need to develop safe and effective countermeasures that can be available

Image credit- shuttershock.com

Image credit- shuttershock.com

To support the preparedness, readiness and response for COVID-19, project proposals are being solicited for developing Diagnostics, Vaccines, Novel Therapeutics, Repurposing of Drugs or any other intervention for control of COVID-19 by Industry/Academia/ Industry-Academia participation.

As part of the research consortium developed by the Department of Biotechnology (DBT), Government of India, research proposals are being called for the following areas-


To develop technologies/Assays/components for diagnosis of coronavirus and SARSCoV-2 including diagnostic methods such as ELISA, Lateral Flow assay, Molecular diagnostics (PCR, Real Time PCR), Colorimetric tests, Chemiluminescence, Immunoassays, cell culture.


Vaccine technology platforms, novel vaccine manufacturing technologies, vaccine candidates and enabling disciplines for corona virus vaccine development

Type of candidate vaccine can be DNA, RNA, Live Attenuated Virus, Non-Replicating Viral Vector, Protein Subunit, Replicating Viral Vector at any stage of development

In-licensing technology for optimization, scale-up and manufacturing

Novel Therapeutics:

To develop in-vitro assay/animal models and standardize challenge studies

Screen existing libraries (Biologicals and Chemicals) and identify potential hits for development

Novel methods of B-cell isolation/ monoclonal antibody development

Repurposing of Drugs:

Develop prophylaxis clinical studies and prioritize in healthcare workers

Evaluate existing marketed drugs under a standard protocol in patients of COVID-19

Any other:

Development of any other intervention/technology related to SARS-CoV-2 outbreak prevention and contro


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account